Skip to main content

Table 6 System suitability study results

From: Development and validation of stability-indicating UPLC method for the determination of gliclazide and its impurities in pharmaceutical dosage forms

System suitability parameters

Observed value

Acceptance criteria

USP plate count

8047

b2000

Tailing factor

1.3

c2.0

% Relative standard deviationa

0.84

c2.0

  1. aSix replicate injections
  2. bNot less then
  3. cNot more than